Principle | Criteria |
---|---|
PID diagnosis | Diagnosis rate |
Biological diagnosis availability | |
Genetic diagnosis availability | |
Prenatal diagnosis availability | |
Newborn screening for SCID | |
Treatments | Anti-infectious availability |
Immunoglobulin availability | |
Vaccine availability | |
Curative treatments | |
Biological and targeted therapies | |
Plasma collection | |
Universal health coverage | Diagnosis reimbursement |
Anti-infectious reimbursement | |
Immunoglobulin reimbursement | |
Vaccine reimbursement | |
Curative treatments reimbursement | |
Biological and targeted therapies reimbursement | |
Specialised centres | National PID specialised centre/network |
Adult PID services | |
Transition care | |
National patient organisations | Established national group in the country |
Professional paid staff | |
Main working areas | |
Registries | National PID registry |
Bone marrow donor registry |